Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Assets (2016 - 2025)

Historic Return on Assets for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to 0.28%.

  • Agios Pharmaceuticals' Return on Assets fell 8100.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year decrease of 8100.0%. This contributed to the annual value of 0.52% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Return on Assets of 0.28% as of Q3 2025, which was down 8100.0% from 0.43% recorded in Q2 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Assets peaked at 1.32% during Q4 2021, and registered a low of 0.45% during Q2 2024.
  • Its 5-year average for Return on Assets is 0.24%, with a median of 0.0% in 2022.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Return on Assets skyrocketed by 14800bps in 2021, and later plummeted by -11500bps in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Assets (Quarter) stood at 1.32% in 2021, then plummeted by -100bps to 0.0% in 2022, then tumbled by -11332bps to 0.37% in 2023, then soared by 206bps to 0.39% in 2024, then tumbled by -173bps to 0.28% in 2025.
  • Its Return on Assets was 0.28% in Q3 2025, compared to 0.43% in Q2 2025 and 0.41% in Q1 2025.